Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00433394 · ClinicalTrials.gov registry record · NA
Registration and Informed Consent Study for the Childhood Cancer Research Network
A NA study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- NA
- Development phase
- 2,242
- Enrollment target
NCT00433394: Completed NA study, sponsored by Children's Oncology Group.
NCT00433394 is a NA study that has completed, run by Children's Oncology Group. The registered enrollment target is 2,242 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00433394, a NA study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,242 participants
- Enrollment target
Study Summary
RATIONALE: Collecting informed consent from parents of children with cancer to register with the Childhood Cancer Research Network may help the study of cancer in the future. PURPOSE: This study is collecting informed consent to register younger patients with cancer into the Childhood Cancer Research Network.
Interventions
- PROCEDURE cancer prevention intervention
- PROCEDURE educational intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,242 participants |
| Start Date | 2001-05 |
| Est. Completion | 2011-01 |
| Phase | NA |
What the finished NCT00433394 record still lists
NCT00433394 is an interventional study that assigns participants to a tested intervention. Its 2,242 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% higher).
The record links to 0 conditions, and to 2 interventions - of which cancer prevention intervention is the first listed.
NCT00433394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00433394 about?
NCT00433394 is a clinical study titled "Registration and Informed Consent Study for the Childhood Cancer Research Network". RATIONALE: Collecting informed consent from parents of children with cancer to register with the Childhood Cancer Research Network may help the study of cancer in the future. PURPOSE: This study is collecting informed consent to register younger patients with cancer into the Childhood Cancer Resear...
What is the current status of trial NCT00433394?
This trial is currently completed. It is a NA study. The enrollment target is 2,242 participants. The study started on 2001-05. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00433394?
The interventions under investigation include: cancer prevention intervention (PROCEDURE), educational intervention (PROCEDURE).
Who is sponsoring clinical trial NCT00433394?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00433394's enrollment target sits among peer trials
2,242 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia